Home
Data
Calendar
Blog
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 34.79 | NA | 34.78 | 33.16 | 32.37 | |
| Weighted Average Number Of Shares Outstanding Basic | 33.50 | NA | 33.28 | 33.16 | 32.37 | |
| Earnings Per Share Basic | 0.70 | -0.29 | 1.07 | -0.78 | -0.21 | |
| Earnings Per Share Diluted | 0.68 | -0.28 | 1.02 | -0.78 | -0.21 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 59.12 | 41.85 | 43.73 | 18.17 | 25.26 | |
| Operating Expenses | 38.01 | 36.94 | 29.72 | 34.47 | 31.04 | |
| Research And Development Expense | 28.61 | 28.29 | 22.19 | 26.30 | 23.10 | |
| General And Administrative Expense | 9.40 | 8.65 | 7.53 | 8.17 | 7.94 | |
| Operating Income Loss | 21.11 | 4.91 | 14.01 | -16.30 | -5.78 | |
| Allocated Share Based Compensation Expense | 3.73 | 3.84 | 3.40 | 3.12 | 2.75 | |
| Income Tax Expense Benefit | 1.83 | NA | -17.40 | 13.85 | 3.55 | |
| Profit Loss | 23.50 | -9.54 | 35.46 | -25.93 | -6.67 | |
| Net Income Loss | 23.50 | -9.54 | 35.46 | -25.93 | -6.67 | |
| Comprehensive Income Net Of Tax | 23.05 | -8.85 | 35.97 | -26.29 | -5.26 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Assets | 510.84 | 469.19 | 485.03 | 493.98 | 475.57 | |
| Liabilities | 241.48 | 226.83 | 238.37 | 287.07 | 245.96 | |
| Liabilities And Stockholders Equity | 510.84 | 469.19 | 485.03 | 493.98 | 475.57 | |
| Stockholders Equity | 269.37 | 242.36 | 246.66 | 206.91 | 229.61 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Assets Current | 414.17 | 369.77 | 383.04 | 390.19 | 434.13 | |
| Cash | 0.50 | 0.50 | 0.50 | 0.50 | 0.30 | |
| Cash And Cash Equivalents At Carrying Value | 68.44 | 67.60 | 51.88 | 79.74 | 227.65 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 72.39 | 71.55 | 55.83 | 83.69 | 231.60 | |
| Prepaid Expense And Other Assets Current | 9.24 | 11.92 | 24.44 | 9.66 | 16.21 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | 17.75 | 17.11 | 16.15 | 15.36 | 13.23 | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 6.75 | 5.92 | 5.11 | 4.34 | 3.84 | |
| Property Plant And Equipment Net | 11.00 | 11.19 | 11.04 | 11.02 | 9.39 | |
| Other Assets Noncurrent | 2.76 | 2.79 | 2.98 | 0.54 | 13.84 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Liabilities Current | 173.94 | 158.80 | 165.43 | 125.94 | 147.59 | |
| Accounts Payable Current | 2.53 | 3.28 | 0.75 | 2.42 | 6.47 | |
| Other Accrued Liabilities Current | 0.74 | 1.00 | 0.94 | 1.09 | 1.18 | |
| Taxes Payable Current | 5.86 | 4.02 | NA | NA | NA | |
| Accrued Liabilities Current | 8.79 | 11.32 | 9.60 | 7.11 | 11.68 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | 58.13 | 60.32 | 62.43 | 65.62 | 9.12 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Stockholders Equity | 269.37 | 242.36 | 246.66 | 206.91 | 229.61 | |
| Additional Paid In Capital | 441.08 | 437.13 | 432.58 | 428.80 | 425.21 | |
| Retained Earnings Accumulated Deficit | -171.47 | -194.97 | -185.43 | -220.89 | -194.96 | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0.25 | 0.20 | -0.50 | -1.00 | -0.64 | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3.73 | NA | 3.40 | 3.12 | 2.75 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -25.52 | -4.01 | -24.49 | -35.09 | 203.40 | |
| Net Cash Provided By Used In Investing Activities | 26.15 | 19.04 | -3.74 | -113.26 | -40.44 | |
| Net Cash Provided By Used In Financing Activities | 0.21 | 0.69 | 0.37 | 0.44 | 19.54 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -25.52 | -4.01 | -24.49 | -35.09 | 203.40 | |
| Net Income Loss | 23.50 | -9.54 | 35.46 | -25.93 | -6.67 | |
| Profit Loss | 23.50 | -9.54 | 35.46 | -25.93 | -6.67 | |
| Share Based Compensation | 3.73 | 3.84 | 3.40 | 3.12 | 2.75 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | 26.15 | 19.04 | -3.74 | -113.26 | -40.44 | |
| Payments To Acquire Property Plant And Equipment | 0.84 | 0.98 | 1.45 | 1.52 | 1.67 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | 0.21 | 0.69 | 0.37 | 0.44 | 19.54 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
|---|---|---|---|---|---|---|
| Pierrepont Therapeutics Inc | 1.00 | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 59.12 | 41.85 | 43.73 | 18.17 | 25.26 | |
| Vertex | 58.10 | 41.85 | 43.74 | 18.17 | NA | |
| Vertex, Collaboration Service Revenue | 2.00 | 5.17 | 3.94 | 3.54 | NA | |
| Vertex, Recognition Of Upfront And Milestone Payments | 38.70 | NA | NA | NA | NA |
